Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CBIO Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the Crescent Biopharma Inc. (NASD:CBIO) seasonal charts above shows that a Buy Date of October 4 and a Sell Date of December 26 has resulted in a geometric average return of 22.67% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 59.64% per year.

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

To download CBIO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CBIO